Abstract:In this study, we optimize the alkyl tails of ionizable lipids for LNP‐mediated delivery of three mRNAs of varying sizes in vivo. Different IL tail lengths were found to be ideal for transfection of LNPs encapsulating the three mRNAs tested. We envision that the results of this project can be utilized as future design criteria for the next generation of LNPs. RNA‐based therapeutics have gained traction for the prevention and treatment of a variety of diseases. However, their fragility and immunogenicity necessitate a drug carrier. Lipid nanoparticles (LNPs) have emerged as the predominant delivery vehicle for RNA therapeutics. An important component of LNPs is the ionizable lipid (IL), which is protonated in the acidic environment of the endosome, prompting cargo release into the cytosol. Currently, there is growing evidence that the structure of IL lipid tails significantly impacts the efficacy of LNP‐mediated mRNA translation. Here, we optimized IL tail length for LNP‐mediated delivery of three different mRNA cargos. Using C12‐200, a gold standard IL, as a model, we designed a library of ILs with varying tail lengths and evaluated their potency in vivo. We demonstrated that small changes in lipophilicity can drastically increase or decrease mRNA translation. We identified that LNPs formulated with firefly luciferase mRNA (1929 base pairs) and C10‐200, an IL with shorter tail lengths than C12‐200, enhance liver transfection by over 10‐fold. Furthermore, different IL tail lengths were found to be ideal for transfection of LNPs encapsulating mRNA cargos of varying sizes. LNPs formulated with erythropoietin (EPO), responsible for stimulating red blood cell production, mRNA (858 base pairs), and the C13‐200 IL led to EPO translation at levels similar to the C12‐200 LNP. The LNPs formulated with Cas9 mRNA (4521 base pairs) and the C9‐200 IL induced over three times the quantity of indels compared with the C12‐200 LNP. Our findings suggest that shorter IL tails may lead to higher transfection of LNPs encapsulating larger mRNAs, and that longer IL tails may be more efficacious for delivering smaller mRNA cargos. We envision that the results of this project can be utilized as future design criteria for the next generation of LNP delivery systems for RNA therapeutics.

Minimizing the ratio of ionizable lipid in lipid nanoparticles for in vivo base editing

Optimized microfluidic formulation and organic excipients for improved lipid nanoparticle mediated genome editing

mRNA‐Loaded Lipid‐Like Nanoparticles for Liver Base Editing Via the Optimization of Central Composite Design

Optimization of lipid nanoparticles for gene editing of the liver via intraduodenal delivery

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique in Vivo RNA Delivery Fates Within the Liver That Alter Therapeutic Outcomes in a Cancer Model

Modulating the Nature of Ionizable Lipids and Number of Layers in Hyaluronan-Decorated Lipid Nanoparticles for In Vitro Delivery of RNAi

Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA

Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3

Engineering branched ionizable lipid for hepatic delivery of clustered regularly interspaced short palindromic repeat-Cas9 ribonucleoproteins

Characterization of Lipid Nanoparticles Containing Ionizable Cationic Lipids Using Design-of-Experiments Approach.

Membrane-destabilizing Ionizable Phospholipids for Organ-Selective Mrna Delivery and CRISPR–Cas Gene Editing

Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing

Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).

Ionizable Lipids from Click Reactions for Lipid Nanoparticle Assembling and Mrna Delivery

Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver

Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety

An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in vivo.

A Systematic Study of Unsaturation in Lipid Nanoparticles Leads to Improved Mrna Transfection in Vivo.

In Silico Engineering of Stable siRNA Lipid Nanoparticles: Exploring the Impact of Ionizable Lipid Concentrations for Enhanced Formulation Stability

Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length

Multicomponent Lipid Nanoparticles for RNA Transfection